SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-011571
Filing Date
2017-05-23
Accepted
2017-05-23 17:16:22
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q toca-10q_20170331.htm 10-Q 1641030
2 EX-31.1 toca-ex311_10.htm EX-31.1 8890
3 EX-31.2 toca-ex312_9.htm EX-31.2 8609
4 EX-32.1 toca-ex321_8.htm EX-32.1 6424
  Complete submission text file 0001564590-17-011571.txt   6683669

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT toca-20170331.xml EX-101.INS 1592817
6 XBRL TAXONOMY EXTENSION SCHEMA toca-20170331.xsd EX-101.SCH 41021
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE toca-20170331_cal.xml EX-101.CAL 42957
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toca-20170331_def.xml EX-101.DEF 176181
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE toca-20170331_lab.xml EX-101.LAB 350365
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toca-20170331_pre.xml EX-101.PRE 289433
Mailing Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109
Business Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109 (858) 412-8400
Tocagen Inc (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 17864662
SIC: 2834 Pharmaceutical Preparations